Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

Twelves, Chris; Wong, A.; P. Nowacki, Marek; Abt, Markus; A. Burris, Howard; Carrato, Alfredo; Cassidy, Jim; Cervantes, Andrés; Fagerberg, Jan; Georgoulias, Vassilis; Husseini, Fares; I. Jodrell, Duncan; Koralewski, P.; Kröning, H.; A. Maroun, Jean; Marschner, Norbert; McKendrick, Joseph; Pawlicki, Marek; Rosso, Riccardo; Schüller, Johannes; Seitz, Jean‐François; Štabuc, Borut; Tujakowski, Jerzy; van Hazel, Guy; Załuski, J.; Scheithauer, Werner

doi:10.1056/nejmoa043116

Public

Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

Published in New England Journal of Medicine • Jun 29, 2005

Authors:

Chris Twelves

A. Wong

Marek P. Nowacki

Abstract

BACKGROUND: Intravenous bolus fluorouracil plus leucovorin is the standard adjuvant treatment for colon cancer. The oral fluoropyrimidine capecitabine is an established alternative to bolus fluorouracil plus leucovorin as first-line treatment for metastatic colorectal cancer. We evaluated capecitabi...

Subject

Capecitabine

Medicine

Fluorouracil

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!